FAQs

The weight loss program membership is a monthly automatic charge to your card. This membership provides selective services at a discounted rate and allows the client to order weight loss medications by the vial.

The monthly membership must remain active for the treatments for the medication vial ordered. For example, if the member ordered a vial that will last them 3 months, the membership is required to stay active for those 3 months.

There are additional discounts if paid in full at sign-up

membership and medication prices are subject to change. Vital Science staff will notify the member prior to price changes.

CANCELLATION POLICY:

Members may cancel their membership (after their minimum vial duration commitment is met). Members are required to provide a notice of cancellation at least 21 days in advance so the next charge can be canceled prior to the automatic payment. Cancellation requests should be emailed to ShannonNP@VitalScienceMed.com

The initial appointment involves a telehealth assessment. Prior to this, you will need to fill out some medical intake forms, which will help provide information about your current situation and past weight loss journey. You will also need to have lab work completed. This can be ordered by VitalScience, or you can have your labs completed by your primary care provider. These labs include: CBC, CMP, TSH, Lipid Panel, and HbA1c. This can be done before your telehealth appointment to expedite your weight loss prescription or can be ordered/discussed during your appointment. During this initial appointment, you will receive education on how to best navigate your diet and exercise while on this treatment and have an opportunity to ask questions

Flexibility to Adjust Your Date

To be considered for GLP1 treatment, you should be in good health with a BMI of 30 or higher, or a BMI above 27 accompanied by a weight-related condition, such as joint pain, high blood pressure or high cholesterol.

Additionally, certain exclusions apply. Individuals under the age of 18, who are pregnant or breastfeeding. There is a personal or family history of medullary thyroid carcinoma (MTC), or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Also not for persons with Pancreatitis or Type 1 diabetes, are not considered candidates for GLP-1 medications. A medical evaluation, including a review of past weight loss efforts, is required before starting treatment.

Simple and Transparent Billing Process

Semaglutide (Wegovy, Ozempic): Clinical trials show an average weight loss of 15% of body weight over 68 weeks.

Tirzepatide (Mounjaro, Zepbound): Depending on the dose, weight loss ranges from 15% to 20% over 72 weeks, making it slightly more effective than semaglutide.

Oral GLP-1

Oral Tirzepatide: Currently, there is not enough data from clinical trials to offer statistics; however, historically, Tirzepatide has achieved higher weight loss over semaglutide when injected, and likely would be the case for the oral form of the medication

Oral Semaglutide: Clinical trials have shown the following average weight loss with different doses of oral semaglutide. estimates suggesting around a 10-15% reduction in body weight

• 14 mg: Approximately 10 pounds (over 26 weeks in one study 
• 25 mg: Approximately 14.8 pounds (over 68 weeks in one study.  
• 50 mg: Approximately 17.5 pounds (over 68 weeks in one study

Request an Invoice for Your Purchase

When discontinuing the medication, a planned approach is needed to avoid regaining weight and to manage any potential withdrawal effects. It best to taper off GLP1 to allow your body to adjust over several weeks or months, this will allow you to check in with how your weight, appetite and mind are responding. Its important while on and after GLP1 medications you adopt an exercise plan and a sustainable diet. Lifestyle changes are necessary to maintain the weight loss after discontinuing. Additional support could include, active hobbies, therapy, psychosocial support, and or other medications.